Drugs / CB-MNC
CB-MNC
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04098029 | Sep 2019 → Dec 2023 | cerebral palsy | State-Financed Health Facility "Samara Regional Medical Center Dinasty" | Unknown | No outcome recorded |
| Phase 2 | NCT03826498 | Jan 2018 → Jan 2024 | cerebral palsy | State-Financed Health Facility "Samara Regional Medical Center Dinasty" | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CB-MNC | “CB-MNC (Cord Blood Mononuclear Cells) infusion from different donors.” NCT04098029 ↗ |
| Known as | Cord Blood Mononuclear Cells | “CB-MNC (Cord Blood Mononuclear Cells) infusion from different donors.” NCT04098029 ↗ |
| Known as | UCB-MNC | “Umbilical Cord Blood Mononuclear Cells (UCB-MNC) Transfusion” NCT03826498 ↗ |
| Modality | Cell therapy | “Umbilical Cord Blood Mononuclear Cells (UCB-MNC) Transfusion” NCT03826498 ↗ |
| Route | Other | “CB-MNC injection from different donors.” NCT03826498 ↗ |